Ryan Zofay: Most Business Owners Don't Have a Strategy Problem, They Have an Influence Problem

Ryan Zofay will present his leadership and business-growth approach at Speak to Scale, a two-day event on October 10–11, 2026, for 140 business owners. He argues that founder influence—not business tactics—is often the growth bottleneck, drawing on his experience building We Level Up, which he describes as a 9-figure behavioral health company. General admission is free, with VIP tickets priced at $297.

Analysis

This is a low-information promotional item, not an earnings or industry catalyst. Its useful signal is a diligence lens: founder dependence can cap growth and raise key-person and execution risk at privately held behavioral-health providers. If We Level Up can institutionalize sales, hiring, and service delivery beyond its founder, that could support scalability; the article offers no independent evidence that this has happened or that the workshop creates material revenue. In behavioral health, any operating gains would still need to survive staffing constraints, payer economics, and state-level oversight—none of which is addressed here.

For public markets, the event’s attendance and ticket economics are too small and unverified to support a trade, and no mapped public issuer is identified. The 1–3 month signal to watch is not event participation but evidence of repeatable operating performance or leadership depth. Over 6–18 months, founder succession, management retention, and stable unit economics would matter more to a buyer or lender than founder-led growth claims. The contrarian point: “influence” is a persuasive coaching frame, but it risks recasting structural issues—weak incentives, insufficient staffing, or poor processes—as a founder communication problem. No price action or sector inference is warranted from this release alone.

Key Decisions for Investors

• No direct trade: the release supplies no public-company exposure or verifiable financial catalyst.
• For private behavioral-health diligence, test whether operations, referral conversion, hiring, and clinical quality persist when the founder is absent; request cohort-level and leadership-retention data rather than relying on coaching claims.
• Treat any future We Level Up growth claim as conditional until supported by audited financials and evidence on payer mix, staffing, and regulatory compliance.
• Revisit the thesis only if independently verifiable evidence shows sustained growth with reduced founder dependence—or, conversely, leadership turnover or operating deterioration that signals key-person risk.